Point-of-Care (PoC) diagnostics Market Size Worth USD 137.11 Billion by 2034 | CAGR: 9.40%

The Point-of-Care (PoC) diagnostics market size is expected to reach USD 137.11 billion by 2034, according to a new study by Polaris Market Research. The report “Point-of-Care (PoC) diagnostics Market Share, Size, Trends, Industry Analysis Report: By Product (Glucose Testing, Hb1Ac Testing, Coagulation), By Mode of Prescription, By End Use, and By Region; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Point-of-Care (PoC) diagnostics are portable and patient-focused testing solutions designed to deliver real-time results outside traditional laboratory settings. The market is driven by the growing shift toward rapid and accurate testing solutions, which aligns directly with the essence of PoC diagnostics. PoC devices provide clinicians with immediate insights that enable timely interventions as healthcare systems continue to highlight faster decision-making. This transformation reduces dependency on centralized labs, improves efficiency in care delivery, and enhances patient outcomes by minimizing delays in diagnosis and treatment.

Questions? Request a sample or make an inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/point-of-care-poc-diagnostics-market/request-for-sample

The PoC diagnostics market is further driven by the advancement of technology, which is redefining the precision and usability of these solutions. Breakthroughs in areas such as biosensors, connectivity, and miniaturization are making medical devices more reliable, portable, and user-friendly for both healthcare providers and patients. These innovations increase diagnostic accuracy and also allow seamless integration with digital health systems, supporting remote monitoring and data-driven healthcare. Together, these advancements are reinforcing the role of PoC diagnostics as a cornerstone of modern, patient-centric care delivery.

Top of FormPoint-of-Care (PoC) diagnostics Market Report Highlights

• In terms of product, in 2024, infectious diseases held a 53.5% revenue share, driven by the critical need for rapid and accurate identification of communicable pathogens.
• Based on mode of prescription, the OTC segment is expected to witness the fastest growth, fueled by rising consumer demand for self-testing kits for conditions like glucose and pregnancy.
• North America led with a 31.4% global share in 2024, supported by its advanced, technology-focused healthcare infrastructure and widespread device accessibility.
• The Asia Pacific market is projected to grow at 3.7% CAGR, driven by improving healthcare access and rising demand for affordable testing solutions.
• A few global key market players include Abbott, BD, bioMérieux, Danaher Corporation, EKF Diagnostics Holdings plc, F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated, QuidelOrtho Corporation, Siemens Healthcare Private Limited, and Thermo Fisher Scientific Inc.

Polaris Market Research has segmented the market report on the basis of product, mode of prescription, end use, and region:

By Product Outlook (Revenue, USD Billion, 2020–2034)

• Glucose Testing
• Hb1Ac Testing
• Coagulation
• Fertility
• Infectious Diseases
  • HIV
  • Clostridium Difficile
  • HBV
  • Pneumonia or Streptococcus Associated Infections
  • Respiratory Syncytial Virus (RSV)
  • HPV
  • Influenza/Flu
  • HCV
  • MRSA
  • TB and Drug-Resistant TB
  • HSV
  • Others
• Cardiac Markers
• Thyroid Stimulating Hormone
• Hematology
• Primary Care Systems
• Decentralized Clinical Chemistry
• Feces
• Lipid Testing
• Cancer Marker
• Blood Gas/Electrolytes
• Ambulatory Chemistry
• Drug Abuse Testing
• Urinalysis

By Mode of Prescription (Revenue, USD Billion, 2020–2034)

• OTC
• Prescription-based

By End Use Outlook (Revenue, USD Billion, 2020–2034)

• Clinics
  • Physician Office
  • Pharmacy & Retail Clinics
  • Non-practice Clinics
  • Urgent Care Clinic
• Hospitals
• Home
• Assisted Living Healthcare Facilities
• Laboratory

By Regional Outlook (Revenue, USD Billion, 2020–2034)

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Vietnam
  • Australia
  • Rest of Asia Pacific
• Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa